MolVerity AI is a international life-sciences technology initiative developing reliability-centered molecular intelligence for early drug discovery, combining artificial intelligence, machine learning, graph neural networks, computational chemistry, predictive toxicology, and model-reliability methods.
Starting with toxicity, MolVerity is designed to expand progressively toward configurable ADMET screening as validated models and customer-relevant endpoints are introduced.
Our mission is to make computational molecular prediction more useful by making its limitations visible.
Build a trusted molecular intelligence platform that helps discovery teams make earlier, more informed and more defensible decisions across progressively broader validated molecular endpoints.
Help drug-discovery teams identify molecular liabilities earlier while understanding the reliability of every prediction.
MolVerity AI aims to contribute to the global's growing life-sciences and artificial-intelligence ecosystem while developing molecular intelligence technology for pharmaceutical R&D and drug-discovery teams globally.
Whether you're evaluating a pilot, exploring a scientific collaboration or considering an investment, we'd welcome the conversation.
